Holen Sie sich die Stockscreener-App
0.5354
5.57%
-0.0316
Handel nachbörslich:
1.96
1.4246
+266.08%
Schlusskurs vom Vortag:
$0.567
Offen:
$0.5737
24-Stunden-Volumen:
269.31K
Relative Volume:
1.00
Marktkapitalisierung:
$25.59M
Einnahmen:
$2.82M
Nettoeinkommen (Verlust:
$-13.47M
KGV:
-0.7874
EPS:
-0.68
Netto-Cashflow:
$-13.61M
1W Leistung:
-0.85%
1M Leistung:
-48.02%
6M Leistung:
-41.80%
1J Leistung:
-53.04%
1-Tages-Spanne:
$0.535
$0.5737
1-Wochen-Bereich:
$0.50
$0.61
52-Wochen-Spanne:
$0.3954
$1.39
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
Firmenname
Neuroone Medical Technologies Corp
Sektor
Branche
Telefon
(952) 426-1383
Adresse
7599 ANAGRAM DR, EDEN PRAIRIE
Vergleichen Sie NMTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 0.99 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
0.24 | 398.00M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
19.90 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1701 | 358.76M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
JUNE
Dhandho Junoon Etf
|
10.94 | 199.45M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
3.00 | 135.65M | 0 | 0 | 0 | 0.00 |
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-03-29 | Herabstufung | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp Aktie (NMTC) Neueste Nachrichten
NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call Highlights: Regulatory Success ... - Yahoo Finance
CTEK Expects Significant Revenue Growth by Fiscal Year 2025 | NMTC Stock News - GuruFocus
NeuroOne Medical (NMTC) Expands Partnership with Zimmer Biomet and Secures Funding | NMTC Stock News - GuruFocus
Neuroone Medical Technologies Corp -Company Now Fully Funded Through At Least Fiscal 2026 - marketscreener.com
NeuroOne secures funding through fiscal 2026, unaffected by tariffs - Investing.com
NeuroOne Secures $11.3M in Fresh Capital, Forecasts Triple-Digit Growth - Stock Titan
NeuroOne Medical (NMTC) Gains Attention with Successful Pediatric Epilepsy Treatment | NMTC Stock News - GuruFocus
Breakthrough: Teen Goes from 10 Seizures Per Night to Zero with New Brain Treatment - Stock Titan
Ronald McClurg Spends US$100k On NeuroOne Medical Technologies Stock - Yahoo
NeuroOne Medical Technologies CEO buys $50,000 in common stock - Investing.com Australia
NeuroOne Medical Technologies CEO buys $50,000 in common stock By Investing.com - Investing.com South Africa
NeuroOne Medical’s CFO Ronald McClurg buys $100,000 in stock By Investing.com - Investing.com South Africa
NeuroOne Medical's CFO Ronald McClurg buys $100,000 in stock - Investing.com
NeuroOne Executives Make Significant Stock Purchases - TradingView
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet - Benzinga
NeuroOne Announces Proposed Public Offering Of Common Stock To Raise Capital For Growth - Nasdaq
Neuroone stock hits 52-week low at $0.48 amid market challenges By Investing.com - Investing.com South Africa
Neuroone stock hits 52-week low at $0.48 amid market challenges - Investing.com
NeuroOne (NMTC) Announces $8 Million Public Offering - GuruFocus
Dow Tumbles 1,100 Points; US Economy Adds 228,000 Jobs In March - Benzinga
NeuroOne Medical Technologies prices $8 million public offering of common stock - MSN
NeuroOne sets price for 16 million share offering - Investing.com
NeuroOne Raises $8M: Inside the Major Public Offering That's Catching Investor Attention - Stock Titan
Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday - Benzinga
NeuroOne announces public offering of common stock - Investing.com
NeuroOne Medical Announces Strategic Stock Offering with Ladenburg Thalmann - Stock Titan
Fostering clinician-led biotech innovation - Medical Economics
Game-Changing Epilepsy Innovation: NeuroOne's FDA-Cleared Device Transforms Brain Treatment - StockTitan
NeuroOne CEO Joins Today's Marketplace To Discuss The Latest Treatments for Epilepsy - Quantisnow
Breakthrough: First-Ever FDA-Cleared Device Transforms Epilepsy Treatment for 50M Patients - StockTitan
Tariffs and medical devices: What has the industry response been? - Medical Economics
NeuroOne Targets May 2025 FDA Submission For OneRF Trigeminal Nerve Ablation System - Nasdaq
NeuroOne accelerates FDA submission timeline for nerve ablation tech - Mass Device
NeuroOne speeds up FDA submission for nerve ablation system - Investing.com
NeuroOne Speeds Up FDA Timeline: Revolutionary Facial Pain Treatment Could Hit Market Earlier Than Expected - StockTitan
NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - Barchart
Can NeuroOne's Upcoming Investor Presentation Signal New Growth in Neurological Tech? - StockTitan
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2025 Earnings Call Transcript - MSN
Earnings call transcript: NeuroOne Medical sees Q1 2025 revenue surge - MSN
NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call Highlights: Record Revenue and ... - Yahoo Finance
Earnings call transcript: NeuroOne Medical sees Q1 2025 revenue surge By Investing.com - Investing.com Canada
NeuroOne Medical Technologies Corp Reports Q1 FY2025 Earnings: E - GuruFocus.com
NEUROONE MEDICAL TECHNOLOGIES Corp SEC 10-Q Report - TradingView
NeuroOne Reports First Quarter Fiscal Year 2025 Financial Results - TradingView
Q1 Earnings Breakthrough: NeuroOne Hits Record $6.3M Revenue as Product Sales Triple - StockTitan
NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. - EIN News
NeuroOne Medical Earnings Alert: Key Q1 2025 Results and Strategic Updates Coming February 12 - StockTitan
NeuroOne regains Nasdaq compliance with share price By Investing.com - Investing.com South Africa
NeuroOne regains Nasdaq compliance with share price - Investing.com
Contrasting NeuroOne Medical Technologies (NASDAQ:NMTC) and Inari Medical (NASDAQ:NARI) - Defense World
Finanzdaten der Neuroone Medical Technologies Corp-Aktie (NMTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):